Company Filing History:
Years Active: 2020-2024
Title: Innovations in Tissue Engineering by Robert V Strouse
Introduction
Robert V Strouse is an accomplished inventor based in Columbus, OH (US). He has made significant contributions to the field of tissue engineering, particularly in the development of vascular grafts. With a total of 3 patents, Strouse's work focuses on optimizing patient-specific solutions that enhance the efficacy of medical treatments.
Latest Patents
Strouse's latest patents include innovative systems and methods for optimized patient-specific tissue engineering vascular grafts. His research has established that optimizing cell seeding onto tissue engineering vascular grafts (TEVG) is associated with reduced inflammatory responses and decreased post-operative stenosis. The findings indicate that cell seeding increases TEVG patency in a dose-dependent manner. Furthermore, while the duration of incubation time has minimal effect on TEVG patency, the optimal number of cells is crucial for maintaining graft patency and reducing post-operative complications. Strouse's patents also describe closed, single-use customizable systems for seeding TEVG, which are designed based on the morphology of the patient-specific graft to enhance cell seeding efficacy.
Career Highlights
Strouse is affiliated with the Research Institute at Nationwide Children's Hospital, where he continues to advance his research in tissue engineering. His work is pivotal in developing innovative solutions that address critical challenges in medical treatments.
Collaborations
Strouse collaborates with notable colleagues, including Christopher K Breuer and Cameron Best, who contribute to the research and development of his innovative projects.
Conclusion
Robert V Strouse's contributions to tissue engineering and his innovative patents are paving the way for advancements in medical treatments. His work exemplifies the importance of research in improving patient outcomes through optimized engineering solutions.